These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 16221871

  • 21. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, Hieshima K, Maruyama H, Miyazaki J, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [Abstract] [Full Text] [Related]

  • 22. Effect of combining ACE inhibitor and statin in lupus-prone mice.
    Shimazu H, Kinoshita K, Hino S, Yano T, Kishimoto K, Nagare Y, Nozaki Y, Sugiyama M, Ikoma S, Funauchi M.
    Clin Immunol; 2010 Aug; 136(2):188-96. PubMed ID: 20403731
    [Abstract] [Full Text] [Related]

  • 23. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
    Fujii T, Okada M, Fujita Y, Sato T, Tanaka M, Usui T, Umehara H, Mimori T.
    J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182
    [Abstract] [Full Text] [Related]

  • 24. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 25. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice.
    Zavala F, Masson A, Hadaya K, Ezine S, Schneider E, Babin O, Bach JF.
    J Immunol; 1999 Nov 01; 163(9):5125-32. PubMed ID: 10528219
    [Abstract] [Full Text] [Related]

  • 26. Dendritic cells contribute to autoimmune kidney injury in MRL-Faslpr mice.
    Iwata Y, Furuichi K, Sakai N, Yamauchi H, Shinozaki Y, Zhou H, Kurokawa Y, Toyama T, Kitajima S, Okumura T, Yamada S, Maruyama I, Matsushima K, Kaneko S, Wada T.
    J Rheumatol; 2009 Feb 01; 36(2):306-14. PubMed ID: 19208562
    [Abstract] [Full Text] [Related]

  • 27. Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.
    Anam K, Amare M, Naik S, Szabo KA, Davis TA.
    Lupus; 2009 Apr 01; 18(4):318-31. PubMed ID: 19276300
    [Abstract] [Full Text] [Related]

  • 28. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 01; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

  • 29. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Dec 01; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 30. Murine lupus in the absence of alpha beta T cells.
    Peng SL, Madaio MP, Hughes DP, Crispe IN, Owen MJ, Wen L, Hayday AC, Craft J.
    J Immunol; 1996 May 15; 156(10):4041-9. PubMed ID: 8621947
    [Abstract] [Full Text] [Related]

  • 31. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Hagiwara E, Okubo T, Aoki I, Ohno S, Tsuji T, Ihata A, Ueda A, Shirai A, Okuda K, Miyazaki J, Ishigatsubo Y.
    Cytokine; 2000 Jul 15; 12(7):1035-41. PubMed ID: 10880249
    [Abstract] [Full Text] [Related]

  • 32. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L, Chen HP, Ma Q.
    Immunol Lett; 2014 Sep 15; 161(1):76-80. PubMed ID: 24837470
    [Abstract] [Full Text] [Related]

  • 33. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M.
    Arthritis Rheum; 2007 May 15; 56(5):1618-28. PubMed ID: 17469144
    [Abstract] [Full Text] [Related]

  • 34. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH.
    Arthritis Rheum; 2004 Jun 15; 50(6):1884-96. PubMed ID: 15188365
    [Abstract] [Full Text] [Related]

  • 35. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis.
    Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G.
    Eur J Immunol; 1995 Jan 15; 25(1):6-12. PubMed ID: 7843255
    [Abstract] [Full Text] [Related]

  • 36. Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine.
    Bednarski JJ, Warner RE, Rao T, Leonetti F, Yung R, Richardson BC, Johnson KJ, Ellman JA, Opipari AW, Glick GD.
    Arthritis Rheum; 2003 Mar 15; 48(3):757-66. PubMed ID: 12632430
    [Abstract] [Full Text] [Related]

  • 37. Knocking out of CD38 accelerates development of a lupus-like disease in lpr mice.
    Viegas MS, Silva T, Monteiro MM, do Carmo A, Martins TC.
    Rheumatology (Oxford); 2011 Sep 15; 50(9):1569-77. PubMed ID: 21586522
    [Abstract] [Full Text] [Related]

  • 38. A central role for alpha beta T cells in the pathogenesis of murine lupus.
    Seery JP, Wang EC, Cattell V, Carroll JM, Owen MJ, Watt FM.
    J Immunol; 1999 Jun 15; 162(12):7241-8. PubMed ID: 10358171
    [Abstract] [Full Text] [Related]

  • 39. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD, Stump KL, Wallace NH, Dobrzanski P, Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Mason JL, Ator MA, Dorsey BD, Ruggeri BA, Seavey MM.
    J Immunol; 2011 Oct 01; 187(7):3840-53. PubMed ID: 21880982
    [Abstract] [Full Text] [Related]

  • 40. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.
    Reilly CM, Olgun S, Goodwin D, Gogal RM, Santo A, Romesburg JW, Ahmed SA, Gilkeson GS.
    Eur J Immunol; 2006 May 01; 36(5):1296-308. PubMed ID: 16541466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.